We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]
Drug Screening/Testing Market | Forecasts up to 2025 | Covid-19 Impact Analysis
This report, from Stratview Research, studies the clinical diagnostics market - drug screening/testing over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
The Burning Questions This Report Will Answer:
In the developed markets such as the USA, the UK, Australia and others, drug tests are considered much more reliable and accurate than simple drug screens, although these tests are lot pricier i.e. ~ $200 and take a lot longer to perform i.e. around 1-7 days. However, these tests are far more in demand for pre-employment services, rehabilitation services, sports & training academy, defence departments and others.
The future of random and pre-employment drug and alcohol testing is expected to be enforced within all job activities at least in all the major markets across the globe. Recent trends in the industry indicate that it will be almost impossible for recreational drug users to get a job with small and larger companies especially in countries like the USA, Germany, the UK, France, GCC, Canada, etc. Enforcing drug testing at work is probably the single most effective weapon the market and the law makers are expecting to use against younger and adult substance abuse.
This report highlights the demand that is expected to come from different sectors in various regions in the next 5-7 years and which can help the manufactures of drug diagnostic kits and reagents and also the services sector to prioritize their marketing plans and product launches accordingly.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global clinical diagnostics market (drug screening) is segmented into the following categories:
By Type of Sample Collection
By Testing Facility
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].